Stevanato Group has beaten earnings estimates in 3 of the last 4 quarters with consistent 5-10% upside surprises and analyst targets implying 28% price upside, but the stock is in a confirmed downtrend with a death cross and free cash flow that is negative 40% relative to net income, creating a gap between earnings quality and analyst optimism.
Thesis pillars
- Earnings Beat Analyst Upside→Stable
- Death Cross Confirmed Downtrend→Stable
- Fcf Earnings Quality Divergence→Stable
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026
Stevanato Group S.p.A. (STVN) Stock Analysis
Range Bound setup
Healthcare · Medical Instruments & Supplies
Sell if holding. Momentum 3.9/10 is below the 5.0 floor at $19.43 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Earnings in 4 days (event risk).
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two... Read more
Sell if holding. Momentum 3.9/10 is below the 5.0 floor at $19.43 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Earnings in 4 days (event risk). Chart setup: RSI 54 mid-range, Bollinger mid-band. Score 4.7/10, moderate confidence.
Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and earnings proximity 4d<=7d. Suitability: moderate.
Recent developments
updated 2026-10-29Recent Developments — Stevanato Group S.p.A.
Latest news
- NEWS Stevanato Group SpA (STVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey — TradingKey neutral
- NEWS Stevanato Group SpA (STVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com — tradingkey.com neutral
- NEWS Stevanato Group (NYSE:STVN) Sees Unusually-High Trading Volume - Should You Buy? - MarketBeat — MarketBeat neutral
- NEWS Stevanato Group SpA (STVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey — TradingKey neutral
- NEWS Stevanato Group SpA (STVN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey — TradingKey neutral
Generated 2026-10-29T11:53:52Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 3.9/10 is below the 5.0 floor at $19.43 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Earnings in 4 days (event risk). Chart setup: RSI 54 mid-range, Bollinger mid-band. Prior stop was $18.21. Score 4.7/10, moderate confidence.
Analyst target: $21.61 (+11.2% upside). Prior stop was $18.21. Stop-loss: $18.21.
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Earnings in 4 days (event risk); Weak overall score: 4.7/10.
Stevanato Group S.p.A. trades at a P/E of 34.1 (forward 23.5). TrendMatrix value score: 4.1/10. Verdict: Sell.
18 analysts cover STVN with a consensus score of 4.2/5. Average price target: $25.
What does Stevanato Group S.p.A. do?Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide...
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.